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Case report. 70 years old woman who presented a syncope clinic in June 2003 Chest X: increased density in the left upper lobe of
the left lung. Chest CT (24/09/2003): 6 cm×6.5 cm×3.5 cm mass in LSI. Fibroscopy: No evidence of neoplastic cells. Percutaneous
biopsy: diffuse lymphoid proliferation with little cellular atypia, compatible with non-Hodgkin lymphoma of low grade malig-
nancy. Sign chemotherapy with partial response on CT and PET with low activity. Adjuvant radiotherapy (35Gy at 1.8Gy/session)
with cobalt bomb. CT Post-Radiation: No evidence of tumor remaining. Subsequent revisions since nowday: no evidence of
disease on imaging test.
Discussion. Primary pulmonary non-Hodgkin’s lymphoma represent <1% of primary malignant lung tumors. PPL might be of
various histopathological types and the most frequently encountered type is the MALT. PPNHL has various clinical symptoms and
that 37.5–50% of patients are asymptomatic. Bronchoscopy may be of limited value, as diagnosis based on endobronchial changes
is rare while the positive predictive rate of a puncture biopsy under CT guidance is only 25%. PPL is generally diagnosed through
an evaluation of large surgical tissue biopsies. Their treatment is controversial and some recent series did not demonstrate any
difference in survival among patients receiving local-regional therapy alone (surgical intervention or irradiation), chemotherapy,
or a combination.
Conclusions. Primary pulmonary non-Hodgkin’s lymphoma are associated with a good prognosis. Chemotherapy (CNOP) plus
adjuvant radiotherapy is shown as a therapeutic option with low toxicity and long survival.
http://dx.doi.org/10.1016/j.rpor.2013.03.342
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Introduction. Primary thyroid lymphoma occurs in less than 3% of all non-Hodgkin’s extranodal lymphoma. To perform a retro-
spective and descriptive study of the patients treated in our centre.
Methods. Two cases of primary thyroid lymphoma that underwent to radiotherapy are described. Both of them was diffuse large B-
cell lymphoma, which is the most common type of this pathology. The ﬁrst case was 74 year-old woman. She was classiﬁcated as
stage IIA-E and was performed thyroid biopsy. The second case was 65 year-old woman. She was classiﬁcated as stage IA-E and
was performed left hemithyroidectomy. Both patients have received chemotherapy with R-CHOP 4× cycles and radiotherapy.
Radiation ﬁelds included thyroid gland (left hemithyroidectomy surgical bed in the second patient), neck nodes and upper
mediastinum nodes to a total dose of 36Gy (5×2Gy). Acute and late toxicity was assessed using the RTOG/EORTC criteria.
Results. With a median follow-up of 9 months, both patients are free of disease. One patient experienced grade I mucositis and
the other one grade II mucositis during radiotherapy. There were no late toxicity.
Conclusion. The typical patient is female and ederly as the literature reports. Therapeutic management is distinct from other
thyroid neoplasias and include surgery, chemotherapy and radiotherapy.
http://dx.doi.org/10.1016/j.rpor.2013.03.343
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Introduction. Primary cutaneous lymphomas (CL) represent 19% of extranodal non-Hodgkin lymphomas (NHLs). Approximately
one-fourth of cutaneous lymphomas are B-cell derived and are generally classiﬁed into three distinct subgroups: primary cuta-
neous follicle-center lymphoma (PCFCL), primary cutaneous marginal zone lymphoma (PCMZL), and primary cutaneous diffuse
large B-cell lymphoma, leg type (PCLBCL, LT). Both PCFCL and PCMZL are indolent lymphomas that may be successfully managed
with local radiation therapy.
Objectives. We reported one case of primary cutaneous marginal PCMZ in the leg treated by VMAT.
Methods. A 36 years-old man started with multiple nodes and itchiness in his right left. Histological analysis and immunohis-
tochemical staining of four adequate skin biopsies showed the following phenotype: CD20, BCL2+; CD23, CD10, BCL6+ in some
cells. Ki67: +15%. B-lymphoma between follicular and marginal. Lymphoma staging estimated a 5-year disease-speciﬁc survival
rate of 95%. The Ann Arbor staging system: IE. The ISCL/EORTC: T2c all-disease-encompassing in a 30-cm diameter circular.
Results. An aquaplastmask was then prepared, molded to the leg of the patient, and locked to the treatment table. A CT scan of
3mm thick slices of the region was subsequently obtained. The optimization constraints were to deliver 100% of the prescribed
dose, V95: 99.1%-V107: 3.3%, of the target volume and to restrict the target volume receiving more than 110% of the prescribed
dose to 0.2%. The prescription dose was 30Gy. We included a 5 cm margin of clinically normal skin within the target volume.
Bolus is needed to increase the dose to the skin surface to 95%, typically 1 cm of bolus is needed for using 6 MV to give photons
a surface dose of >95% and a depth dose 10mm.
Conclusions. VMAT is an appropriate technique for treating cutaneous lymphomas.
http://dx.doi.org/10.1016/j.rpor.2013.03.344
